- Home
- ESRT vs SANA Comparison
ESRT vs SANA Comparison
Compare ESRT & SANA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ESRT | SANA |
|---|---|---|
| Founded | 2011 | 2018 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Medicinal Chemicals and Botanical Products |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 907.0M | 793.1M |
| IPO Year | 2012 | 2021 |
Fundamental Metrics
Financial Performance| Metric | ESRT | SANA |
|---|---|---|
| Price | $5.60 | $3.14 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 3 | 5 |
| Target Price | $6.35 | ★ $7.80 |
| AVG Volume (30 Days) | 2.1M | ★ 3.5M |
| Earning Date | 04-29-2026 | 05-07-2026 |
| Dividend Yield | ★ 2.49% | N/A |
| EPS Growth | N/A | ★ 17.24 |
| EPS | ★ 0.01 | N/A |
| Revenue | ★ $768,270,000.00 | N/A |
| Revenue This Year | $4.26 | N/A |
| Revenue Next Year | $1.52 | N/A |
| P/E Ratio | $576.00 | ★ N/A |
| Revenue Growth | ★ 0.05 | N/A |
| 52 Week Low | $4.87 | $2.61 |
| 52 Week High | $8.07 | $6.55 |
Technical Indicators
Market Signals| Indicator | ESRT | SANA |
|---|---|---|
| Relative Strength Index (RSI) | 52.30 | 39.35 |
| Support Level | $5.23 | $3.03 |
| Resistance Level | $5.82 | $3.41 |
| Average True Range (ATR) | 0.15 | 0.26 |
| MACD | 0.03 | -0.09 |
| Stochastic Oscillator | 46.34 | 6.06 |
Price Performance
Historical ComparisonAbout ESRT Empire State Realty Trust Inc.
Empire State Realty Trust Inc is a real estate investment trust (REIT) that owns and operates office, retail, and multifamily properties located in New York City, prominently in Manhattan. Its portfolio includes office and retail space as well as residential units. The company's objective is to maximize cash flow and total returns to its shareholders and to increase the value of the properties. Its reportable segments consist of a real estate segment and an Observatory segment. The majority of revenue is derived from the Real Estate segment, which includes all activities related to the ownership, management, operation, acquisition, redevelopment, repositioning and disposition of its traditional real estate assets.
About SANA Sana Biotechnology Inc.
Sana Biotechnology Inc is a biotechnology company. The company develops engineered cells as medicines and therapies to treat diseases. It is engaged in developing cell engineering programs across a broad array of therapeutic areas with unmet treatment needs, including oncology, diabetes, B-cell-mediated autoimmune, and central nervous system (CNS) disorders, among others. Its pipeline of product candidates comprises SC291, SC262, UP421, and others.